Phase II trial of guadecitabine priming and pembrolizumab in platinum resistant recurrent ovarian cancer.

Abstract

6025

Document Details

• Document Type: Pub Defense Publication
• Publication Date: May 20, 2020
• Source ID: 10.1200/jco.2020.38.15_suppl.6025

Entities

People

• Alok Pant
• Andreea Gavrilescu
• Bin Zhang
• Daniela E. Matei
• Edward J. Tanner
• Gini F. Fleming
• Horacio Cardenas
• Jiahui Xu
• John William Moroney
• Manoj Kandpal
• Masha Kocherginsky
• Ramana V Davuluri
• Siqi Chen
• Wendy M Swetzig

Organizations

• Northwestern University
• Robert H. Lurie Comprehensive Cancer Center
• United States Department of Defense
• University of Chicago